In October the British Medical Association (BMA) reported it had found cases of private labs groups offering direct-to-consumer at-home diagnostic tests with ‘misleading’ claims about their accuracy, claiming some of these tests are unregulated. The NHS says such tests risk overburdening GPs with patients who have received misleading information. HBI speaks to Kevin Dryhurst, CEO of private labs operator DAM Health, who argues privately provided direct-to-consumer tests have a role to play in providing some of the preventive care which the NHS is failing to deliver.
December 16, 2022
